Suppr超能文献

患者体细胞来源的人类人工卵子:过去、现在和未来。

Human artificial oocytes from patients' somatic cells: past, present and future.

机构信息

MARGen Clinic, Granada, Spain.

MARGen-Mendoza-Tesarik Foundation, Granada, Spain.

出版信息

Reprod Fertil. 2021 Jan 5;2(1):H1-H8. doi: 10.1530/RAF-20-0039. eCollection 2021 Jan.

Abstract

UNLABELLED

The first attempts at generating functional human oocytes by using the transfer of patients' somatic cell nuclei, as DNA source, into donor enucleated oocytes date back to the early 2000s. After initial attempts, that gave rather encouraging results, the technique was abandoned because of adverse results with this technique in the mouse model. Priority was then given to the use of induced pluripotent stem (iPS) cells, based on excellent results in the mouse, where mature oocytes and live healthy offspring were achieved. However, these results could not be reproduced in humans, and oogenesis with human iPS cells did not continue beyond the stage of oogonium. These data suggest that the use of enucleated donor oocytes will be necessary to achieve fertilizable human oocytes with somatic cell-derived DNA. The main problem of all these techniques is that they have to meet with two, sometimes contradictory, requirements: the haploidization of somatic cell-derived DNA, on the one hand, and the remodeling/reprogramming of DNA of somatic cell origin, so as to be capable of supporting all stages of preimplantation and postimplantation development and to give rise to all cell types of the future organism. Further research is needed to determine the optimal strategy to cope with these two requirements.

LAY SUMMARY

The recourse to artificial oocytes, generated by using the patient's own DNA derived from cells of somatic origin, represents the ultimate opportunity for women who lack healthy oocytes of their own but yearn for genetically related offspring. Many different pathologies, such as ovarian cancer, premature ovarian failure, other ovarian diseases and natural, age-related ovarian decay can cause the absence of available oocytes. The demand for artificial oocytes is increasing continuously, mainly because of the tendency to postpone maternity to still more advanced ages, when the quantity and quality of oocytes is low. This minireview focuses on the generation of artificial oocytes using different strategies and scenarios, based on the accumulated experience in humans and experimental animals.

摘要

未加说明

早在 21 世纪初,就有人尝试通过将患者体细胞的细胞核作为 DNA 来源,转移到去核的供体卵母细胞中,从而产生有功能的人类卵母细胞。最初的尝试取得了相当鼓舞人心的结果,但由于在小鼠模型中该技术的不良结果,该技术被放弃。随后,人们将重点放在使用诱导多能干细胞(iPS)上,这是基于在小鼠中取得的优异结果,在小鼠中获得了成熟的卵母细胞和活的健康后代。然而,这些结果在人类中无法重现,并且人类 iPS 细胞的卵发生不能超过卵原细胞阶段。这些数据表明,为了获得具有体细胞源性 DNA 的可受精的人类卵母细胞,有必要使用去核的供体卵母细胞。所有这些技术的主要问题是,它们必须满足两个有时相互矛盾的要求:一方面是体细胞源性 DNA 的单倍体化,另一方面是体细胞源性 DNA 的重塑/重编程,以便能够支持植入前和植入后的所有阶段发育,并产生未来生物体的所有细胞类型。需要进一步研究以确定应对这两个要求的最佳策略。

概述

利用患者自身源自体细胞的 DNA 生成人工卵母细胞,为那些自身缺乏健康卵母细胞但渴望遗传相关后代的女性提供了最终的机会。许多不同的疾病,如卵巢癌、卵巢早衰、其他卵巢疾病和自然的、与年龄相关的卵巢衰退,都可能导致卵母细胞无法获得。对人工卵母细胞的需求不断增加,主要是因为人们倾向于将生育年龄推迟到更晚的年龄,此时卵母细胞的数量和质量都较低。这篇综述文章主要关注使用不同策略和方案生成人工卵母细胞,这些策略和方案是基于在人类和实验动物中积累的经验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a24e/8812406/271254afc9c1/RAF-20-0039fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验